Photo of Krysten Rosen Moller

Krysten Rosen Moller

Krysten Rosen Moller focuses her practice on representing clients in internal investigations, government investigations, and follow-on civil litigation, with an emphasis on serving clients in the life sciences and healthcare industries.

Krysten assists companies with complex internal and government investigations covering a broad range of issues, including fraud and abuse, advertising and promotion, and bribery and corruption. Krysten has particular experience conducting targeted and efficient internal investigations and representing pharmaceutical and medical device companies against investigations from the Department of Justice or other government regulators. Krysten’s complementary litigation practice focuses on defending life sciences and healthcare companies in related litigation, including cases arising under the False Claims Act and other follow-on litigation arising from government investigations.

Krysten also counsels clients on compliance matters. She regularly represents companies negotiating HHS OIG Corporate Integrity Agreements (CIAs) and advises companies on implementing and operating under CIAs. She has also conducted False Claims Act risk assessments and advised on other fraud and abuse issues.

On October 31, 2014, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) released its Work Plan for fiscal year 2015.  Appendix B of the Work Plan outlines OIG’s plans for continued oversight of HHS agencies’ use of American Recovery and Reinvestment Act of 2009 (Recovery Act) funds.
Continue Reading Recovery Act Reviews Outlined in HHS OIG’s Work Plan for Fiscal Year 2015 Focus on EHR Incentive Payments

On November 4, 2014, Health and Human Services (HHS) Secretary Sylvia M. Burwell named a new member to the Health Information Technology Policy Committee (HITPC) and renewed appointments for three members of the Health Information Technology Standards Committee (HITSC).
Continue Reading HHS Secretary Names Members for Health Information Technology Policy Committee and Health Information Technology Standards Committee

On October 14, 2014, the American Medical Association (AMA) outlined its vision for the Electronic Health Record (EHR) Meaningful Use (MU) Program in a letter to the Centers for Medicare & Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology.  Despite the MU program’s achievements since its creation in 2009, the AMA believes “it is important and necessary to pause and fully assess what is working and what needs improvement before moving ahead to Stage 3 of the program.” 
Continue Reading AMA Recommends Improvements to Meaningful Use Program